Detalles de la búsqueda
1.
Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast cancer pre-treated with taxanes and anthracycline: OnSITE study.
Breast J
; 25(2): 219-225, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30734437
Resultados
1 -
1
de 1
1
Próxima >
>>